Clinical Trial Update: HIV Vaccine Designed for HIV Infected Adults Taking Anti-HIV Drugs [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of an HIV vaccine designed for HIV-infected adults on antiretroviral therapy has completed, assessing safety and immune responses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1 | Status: COMPLETED